Patient preferences for chemotherapies used in breast cancer. - Wikidata - awgldk - TriplyDB

Patient preferences for chemotherapies used in breast cancer.

Patient preferences for chemotherapies used in breast cancer.

http://www.wikidata.org/entity/Q36136363

about

Patient preferences and treatment adherence among women diagnosed with metastatic breast cancer A descriptive review on methods to prioritize outcomes in a health care context.Willingness to pay to avoid metastatic breast cancer treatment side effects: results from a conjoint analysis.Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment.Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany Targets for Neoadjuvant Therapy - The Preferences of Patients with Early Breast Cancer.Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.Discerning the clinical relevance of biomarkers in early stage breast cancer.Efficacy and safety of pirarubicin plus capecitabine versus pirarubicin plus cyclophosphamide in Chinese node-negative breast cancer patients: a 4-year open-label, randomized, controlled study.Preference weights for chemotherapy side effects from the perspective of women with breast cancer.

P2860

Q34720400-659AAA11-3659-4C76-97FF-1CACBFD12492 Q35231568-A1306047-425B-46C3-8E5F-EC1D7BBAFC5A Q35661600-24B1CD74-764F-424D-9631-64DDEAE560CB Q36183227-4A2B0589-8F5F-47D0-8FC8-6F7A7C561BC0 Q36214394-06BEA3F8-29B8-494D-99C9-F7AD6B5567C3 Q36917634-1A07C29F-C2F5-4226-9219-27E0273AD538 Q37589074-7361A884-4339-4378-ACE4-2C2280E40A76 Q38841237-C9267318-E1ED-4B00-A974-3E58FC28792A Q41394455-D7CE7141-A431-42AD-B76E-421D787285C4 Q48151443-D471495E-83C6-4D7E-953F-A7FEB91ABC7E

P2860

Patient preferences for chemotherapies used in breast cancer.

http://www.wikidata.org/entity/Q36136363

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Patient preferences for chemotherapies used in breast cancer.

@ast

Patient preferences for chemotherapies used in breast cancer.

@en

type

label

Patient preferences for chemotherapies used in breast cancer.

@ast

Patient preferences for chemotherapies used in breast cancer.

@en

prefLabel

Patient preferences for chemotherapies used in breast cancer.

@ast

Patient preferences for chemotherapies used in breast cancer.

@en

P1433

Q36136363-7DBF77C0-A26E-476E-9A01-07EC0CA38C7A

P1476

Q36136363-5B307746-179E-4CA0-A1F3-0913EAE24C7D

P2093

Q36136363-04396F04-453C-4B19-AE02-FFFAE90D0282

Q36136363-0AE9C53A-1630-4CB6-9EAB-F5935EBD4E5D

Q36136363-0D7A7B8D-1FB4-41ED-839E-FAF6A87E8483

Q36136363-9BE4DF63-A620-49A8-89B1-1744F33880AB

Q36136363-9F3ADDAC-597D-4169-A784-E9E7E22BC4FB

P2860

Q36136363-27D0334F-AA93-455F-AF44-D7FD59222A7D

Q36136363-30D5E6FD-EF4A-4826-9669-55DC83C45239

Q36136363-32310B36-B025-49F6-A7C2-3256C71C1F45

Q36136363-7B960B02-6E50-497A-BD11-09376FB20678

Q36136363-CA4D520D-9360-44FD-BA70-D24F7EAAEC0F

Q36136363-D20364EA-E168-42CE-AE1E-7A15C1546A95

Q36136363-E648C976-95CB-4BF5-BF3D-06FEA25DE399

Q36136363-E861712F-293A-41CD-B848-78D432F3955C

P304

Q36136363-D61CA477-72B9-458A-8661-20A4EDFC807C

P31

Q36136363-8BE66615-1DAF-4A1A-9D6E-26555DEB58AF

P356

Q36136363-9E663F6F-5CF5-4ED9-BA04-E09AB50B0798

P407

Q36136363-D3292055-A51F-4906-A6FB-CB5F4078FD85

P478

Q36136363-84C98F98-E137-4739-B7CA-8C20BC134B42

P577

Q36136363-5A551321-08B4-4EF5-ADE7-4B8A170C58D6

P5875

Q36136363-908230D5-91D3-4BA2-B72D-DAC6C3E3DA89

P698

Q36136363-22B4256D-B931-43AB-B7AA-F9024B93A37C

P921

Q36136363-E1D39E99-2D94-462D-863B-B2935683B430

P932

Q36136363-F3B766CE-7E3F-459D-AF02-7855E255C5E0

P356

P1433

International Journal of Women's Health

P1476

Patient preferences for chemotherapies used in breast cancer.

@en

P2093

Adam Brufsky

http://www.w3.org/2001/XMLSchema#string

Constance Visovsky

http://www.w3.org/2001/XMLSchema#string

Jessica Grinspan

http://www.w3.org/2001/XMLSchema#string

Kathleen Beusterien

http://www.w3.org/2001/XMLSchema#string

Thomas Tencer

http://www.w3.org/2001/XMLSchema#string

P2860

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.

Using conjoint analysis to elicit preferences for health care

Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study.

Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force.

Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.

Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.

Patient preferences among third agent HIV medications: a US and German perspective

P304

279-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJWH.S31331

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230624300

http://www.w3.org/2001/XMLSchema#string

P698

22870042

http://www.w3.org/2001/XMLSchema#string

P921

P932

3410702

http://www.w3.org/2001/XMLSchema#string